ライフサイエンスコーパス: beta particle

1 lf-absorption effect, typical for low-energy beta particles.

2 f secondary electrons in c-Si by the primary beta-particles.

3 varied significantly in their absorption of beta-particles.

4 nosis ((155)Tb) and for alpha- ((149)Tb) and beta(-)-particle ((161)Tb) therapy.

5 ionuclides that emit low-energy electrons or beta particles (169Er, 117mSn, and 33p) were evaluated.

6 tent cytotoxicity of alpha-particles than of beta-particles, (211)At-labeled agents may be ideal for

7 increase the steady-state level of apo B100-beta particles above that of apo B100 particles in contr

8 (64)Cu emits positrons as well as beta(-) particles and Auger and internal conversion elec

9 bution of a radioisotope that emits alpha or beta particles, and show empirically that the null funct

10 In recent years, new alpha-particle-, beta(-)-particle-, and Auger electron-emitting radiometa

11 the Au-198 isotope; the range of the (198)Au beta-particle (approximately 11 mm in tissue or approxim

12 gations, recent calculations have shown that beta particles, because of their helicity, radiolyse L-

13 tion of whether absorption and scattering of beta-particles by stent struts will cause significant pe

14 We also developed a solid-state beta-particle camera imbedded directly below the microfl

15 The limited range of beta-particles compared with gamma-radiation, however, o

16 models, radionuclide S values (electron and beta particle components only) were subsequently calcula

17 Evidence supporting the use of beta-particle, electron, and alpha-particle-emitting rad

18 g a radionuclide with short-range (alpha- or beta-particle) emissions.

19 om the penetrating nature of the high-energy beta particles emitted by the radionuclides.

20 The beta particles emitted from the (90)Sr generate blue lig

21 The short-range beta-particles emitted by [3H]dTTP result in self-irradi

22 Since the alpha- and beta-particles emitted during the decay of radioisotopes

23 EG) chains linked to DOTA for complexing the beta-particle emitter (177)Lu and to panitumumab for tar

24 notherapy with these bsRICs labeled with the beta-particle emitter (177)Lu or the Auger electron-emit

25 The low-energy beta-particle emitter 33P appears to offer a substantial

26 stantial dosimetric advantage over energetic beta-particle emitters (e.g., 32p, 89Sr, 186Re) for irra

27 delivered by Ab LL1, both Auger electron and beta-particle emitters can produce specific and effectiv

28 a large dosimetric advantage over energetic beta-particle emitters for alleviating bone pain, and po

29 The beta-particle emitters had considerably higher levels of

30 rs, (111)In, 67Ga, and 125I, and to evaluate beta-particle emitters, 131I and 90Y.

31 kill than other Auger electron emitters and beta-particle emitters, using an anti-CD74 antibody (Ab)

32 ed currently for clinical dose estimates for beta-particle emitters.

33 Unlike beta particle-emitting isotopes, alpha emitters can sele

34 as to evaluate the dose-related effects of a beta-particle-emitting radioactive stent in a porcine co

35 There were seven beta-particle-emitting radioisotope stents (32P, activit

36 Cerenkov luminescence, the light produced by beta-particle-emitting radionuclides such as clinical po

37 ivo bremsstrahlung with the high-energy pure beta-particle-emitting radionuclides used for therapeuti

38 rivascular space of vessels treated with the beta-particle-emitting stent compared with control vesse

39 e of low-dose endovascular irradiation via a beta-particle-emitting stent inhibits neointimal formati

40 estigate whether low-dose irradiation from a beta-particle-emitting stent would inhibit neointimal pr

41 % versus 36.0 +/- 10.7%, P = .02) within the beta-particle-emitting stents compared with the control

42 (32)P beta-particle-emitting stents have adverse vascular effe

43 We studied the vascular effects of beta-particle-emitting stents in normal canine coronary

44 The arterial placement of (32)P beta-particle-emitting stents in various experimental an

45 erwent placement of 35 nonradioactive and 39 beta-particle-emitting stents with activity levels of 23

46 166Ho with beta-emission (half-life, 26.8 h; beta-particle energies, 1.85 MeV [51%] and 1.77 MeV [48%

47 red more directly, with no dependency on the beta-particle energy.

48 The corresponding beta particles flux levels emitted from the recessed dis

49 rrow are comparable to the mean range of the beta particles for a wide variety of beta-emitting radio

50 Moreover, autoradiography, which recorded beta particles from (198)Au, enabled visualizing the het

51 ere obtained with only a few hundred emitted beta particles from the (90)Y/(90)Sr source or conversio

52 Relativistic beta particles from the nuclear decay of 90 Sr and 90Y g

53 biologic effectiveness equivalent to that of beta particles) from a low-dose rate 137Cs irradiator.

54 imaging system comprising a microchip and a beta-particle imaging camera permitted routine cell-base

55 mity to the radioisotope convert the emitted beta(-) particles into photons having wavelengths in the

56 erential response to the doses of continuous beta-particle irradiation used in this experimental mode

57 However, the clinically useful beta particles may be a source of radiation-induced dama

58 cy using radionuclides that emit short-range beta particles or conversion electrons (CEs).

59 by using radionuclides that emit short-range beta particles or conversion electrons.

60 Snrc radiation transport code for photon and beta-particle organ dosimetry.

61 The ability to image beta particles, positrons, and conversion electrons make

62 t localizes in skeletal metastases and emits beta particles that may be therapeutically beneficial.

63 d with no therapy, alpha- ((149)Tb-cm09) and beta(-)-particle therapy ((161)Tb-cm09) resulted in a ma

64 icles if >/=3 attributes are measured or for beta particles with five attributes measured.

65 above unpackaged p-i-n photodiodes to detect beta-particles with maximum efficiency.

66 dition, the cross-fire effect of high-energy beta(-)-particles within the bone and the marrow may del